Pseudomyxoma peritonei of 92 chinese patients: Clinical characteristics, pathological classification and prognostic factors

World Journal of Gastroenterology

Volumn 18, Issue 24, 2012, Pages 3081-3088

  Guo, Ai Tao ^a   Li, Yan Mi ^a   Wei, Li Xin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Classification; Clinical; Pathologic; Prognosis; Pseudomyxoma peritonei

Indexed keywords

ABDOMINAL DISTENSION; ABDOMINAL MASS; ABDOMINAL PAIN; ADULT; AGED; APPENDIX TUMOR; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SURVIVAL; CHINESE; CLINICAL FEATURE; DISSEMINATED PERITONEAL ADENOMUCINOSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; OVARY TUMOR; OVERALL SURVIVAL; PATHOLOGY; PERITONEAL MUCINOUS CARCINOMATOSIS; PERITONEAL MUCINOUS CARCINOMATOSIS WITH INTERMEDIATE OR DISCORDANT FEATURE; PERITONEUM PSEUDOMYXOMA; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; WEIGHT REDUCTION;

EID: 84863914609     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i24.3081     Document Type: Article

References (36)

1. Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 1997; 16: 1-9.
2. Dong Y, Li T, Zou W, Liang Y. [Pseudomyxoma peritonei: report of 11 cases with a literature review]. Zhonghua Binglixue Zazhi 2002; 31: 522-525.
3. Galani E, Marx GM, Steer CB, Culora G, Harper PG. Pseudomyxoma peritonei: the 'controversial' disease. Int J Gynecol Cancer 2003; 13: 413-418.
4. Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 2003; 27: 1089-1103.
5. Smeenk RM, Verwaal VJ, Zoetmulder FA. Pseudomyxoma peritonei. Cancer Treat Rev 2007; 33: 138-145.
6. Gatalica Z, Loggie B. COX-2 expression in pseudomyxoma peritonei. Cancer Lett 2006; 244: 86-90.
7. Guo AT, Song X, Wei LX, Zhao P. Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry. World J Gastroenterol 2011; 17: 3531-3537.
8. Kojimahara T, Nakahara K, Shoji T, Sugiyama T, Takano T, Yaegashi N, Yokoyama Y, Mizunuma H, Tase R, Satou H, Tanaka T, Motoyama T, Kurachi H. Identifying prognostic factors in Japanese women with pseudomyxoma peritonei: a retrospective clinico-pathological study of the Tohoku Gynecologic Cancer Unit. Tohoku J Exp Med 2011; 223: 91-96.
9. Bruin SC, Verwaal VJ, Vincent A, van't Veer LJ, van Velthuysen ML. A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin. Ann Surg Oncol 2010; 17: 2330-2340.
10. Evers DJ, Verwaal VJ. Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin. Br J Surg 2011; 98: 287-292.
11. Shen DH, Ng TY, Khoo US, Xue WC, Cheung AN. Pseudomyxoma peritonei--a heterogenous disease. Int J Gynaecol Obstet 1998; 62: 173-182.
12. Lee KR, Scully RE. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'. Am J Surg Pathol 2000; 24: 1447-1464.
13. Lee JK, Song SH, Kim I, Lee KH, Kim BG, Kim JW, Kim YT, Park SY, Cha MS, Kang SB. Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005). Int J Gynecol Cancer 2008; 18: 916-920.
14. Imaoka H, Yamao K, Salem AA, Mizuno N, Takahashi K, Sawaki A, Isaka T, Okamoto Y, Yanagisawa A, Shimizu Y. Pseudomyxoma peritonei caused by acute pancreatitis in intraductal papillary mucinous carcinoma of the pancreas. Pancreas 2006; 32: 223-224.
15. Takeuchi M, Matsuzaki K, Yoshida S, Nishitani H, Uehara H. Localized pseudomyxoma peritonei in the female pelvis simulating ovarian carcinomatous peritonitis. J Comput Assist Tomogr 2003; 27: 622-625.
16. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 1995; 19: 1390-1408.
17. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001; 92: 85-91.
18. Jackson SL, Fleming RA, Loggie BW, Geisinger KR. Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients. Mod Pathol 2001; 14: 664-671.
19. Mohamed F, Gething S, Haiba M, Brun EA, Sugarbaker PH. Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process. J Surg Oncol 2004; 86: 10-15.
20. Bradley RF, Stewart JH, Russell GB, Levine EA, Geisinger KR. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 2006; 30: 551-559.
21. van Ruth S, Acherman YI, van de Vijver MJ, Hart AA, Verwaal VJ, Zoetmulder FA. Pseudomyxoma peritonei: a review of 62 cases. Eur J Surg Oncol 2003; 29: 682-688.
22. Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005; 241: 300-308.
23. Gupta S, Parsa V, Adsay V, Heilbrun LK, Smith D, Shields AF, Weaver D, Philip PA, El-Rayes BF. Clinicopathological analysis of primary epithelial appendiceal neoplasms. Med Oncol 2010; 27: 1073-1078.
24. Guo AT, Wei LX, Song X. [Histologic classification and prognostic implication of pseudomyxoma peritonei]. Zhonghua Binglixue Zazhi 2007; 36: 474-479.
25. Sherer DM, Abulafia O, Eliakim R. Pseudomyxoma peritonei: a review of current literature. Gynecol Obstet Invest 2001; 51: 73-80.
26. Lee BY, Kim HS, Lee SH, Moon HS, Cho SM, Lee KH, Song KS, Min KO, Seo EJ, Lee JM. Pseudomyxoma peritonei: extraperitoneal spread to the pleural cavity and lung. J Thorac Imaging 2004; 19: 123-126.
27. Wang CY, Gu MJ, Wang SX, Ma D. Analysis of the clinical pathologic characteristic and prognosis with pseudomyxoma peritone. Xiandai Fuchanke Jinzhan 2002; 11: 268-270.
28. Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 2008; 15: 526-534.
29. Baratti D, Kusamura S, Nonaka D, Cabras AD, Laterza B, Deraco M. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg 2009; 249: 243-249.
30. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 2007; 245: 104-109.
31. Elias D, Honoré C, Ciuchendéa R, Billard V, Raynard B, Lo Dico R, Dromain C, Duvillard P, Goéré D. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 2008; 95: 1164-1171.
32. Elias D, Gilly F, Quenet F, Bereder JM, Sidéris L, Mansvelt B, Lorimier G, Glehen O. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2010; 36: 456-462.
33. Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, Morris DL. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol 2009; 16: 1903-1911.
34. Cioppa T, Vaira M, Bing C, D'Amico S, Bruscino A, De Simone M. Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei. World J Gastroenterol 2008; 14: 6817-6823.
35. Järvinen P, Järvinen HJ, Lepistö A. Survival of patients with pseudomyxoma peritonei treated by serial debulking. Colorectal Dis 2010; 12: 868-872.
36. Arjona-Sánchez Á, Muñoz-Casares FC, Rufián-Peña S, DíazNieto R, Casado-Adam Á, Rubio-Pérez MJ, Ortega-Salas R. Pseudomyxoma peritonei treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results from a single centre. Clin Transl Oncol 2011; 13: 261-267.